Bristol Ophthalmology and Immunology partner in £26.5M NIHR funding 19 August 2011 Professor Andrew Dick leads the Inflammation and Immunotherapeutics theme of the new Moorfields/UCL Institute of Ophthalmology Biomedical Research Centre
- Biomarker Enterprise to Attack Diabetic Kidney Disease Project 22 February 2017 Professor Richard Coward will be leading the BEAt-DKD (Biomarker Enterprise to Attack Diabetic Kidney Disease) project, part of a major pan-European €28.9 million initiative, which will explore the molecular mechanisms underpinning DKD. The project will allow the teams in the School of Clinical Sciences, led by Professor Coward together with Professor Moin Saleem and Dr Simon Satchell, to work closely together on this issue.
- GW4 Building Communities Initiator Grant 9 February 2017 Katy Turner has been successful in the 6th round of GW4 Building Communities awards for “Systems approaches to antimicrobial resistance in different environments”.
- Professor Colin Dayan returns to the University of Bristol 27 January 2017 Diabetes expert Prof Colin Dayan begins a joint role linking his current post at Cardiff University with a new appointment as Professor of Diabetes and Endocrinology at the University of Bristol.
- Diabetes UK Scholarship 25 January 2017 Dr Kathleen Gillespie, Alistair Williams and Anna Long have received £95,308 for a Diabetes UK Scholarship which will allow Claire Williams to investigate the mechanisms underlying natural regulation of the autoimmune response to Zinc Transporter 8.
- Professor Alastair Hay appointed to NICE committee for managing infections 24 January 2017 Alastair Hay, Professor of Primary Care at the University of Bristol’s Centre for Academic Primary Care (CAPC), has been appointed to the National Institute of Health and Care Excellence (NICE) Management of Common Infections committee.
- Diabetes Research and Wellness Foundation Fellowship award success 18 January 2017 Dr Jody Ye, a postdoctoral researcher in the Diabetes and Metabolism Unit in the School of Clinical Sciences, was awarded the Diabetes Research and Wellness Foundation Non-Clinical Fellowship.
- Stewardship policy reduces antimicrobial use on farms 12 January 2017 Evidence suggests the frequent use of certain antimicrobials (AM) in food-producing animals may reduce their effectiveness as treatments for both animals and humans. Researchers at the University of Bristol’s School of Veterinary Sciences are finding novel ways to address these concerns, working with farmers to empower them to develop policies to promote more responsible use of medicines on farms. The new stewardship policy – facilitated by the AMR Force research group - is already informing industry and legislative bodies, allowing them to deliver real, on-farm changes while maintaining or improving herd health and welfare.
- New research describes how bacteria resists ‘last-resort’ antibiotic 10 January 2017 An international research team, led by the University of Bristol, has provided the first clues to understand how the mcr-1 gene protects bacteria from colistin – a ‘last resort’ antibiotic used to treat life-threatening bacterial infections that do not respond to other treatment options. Last year, members of the team, led by Dr Jim Spencer from the School of Cellular and Molecular Medicine, in collaboration with colleagues from Oxford, Cardiff, Diamond Light Source, Thailand and China, identified mcr-1 as the first colistin-resistance gene that could be passed between bacteria, enabling resistance to spread rapidly within a bacterial population.
- Diabetes and Metabolism Group recognition 9 January 2017 Bristol's Diabetes and Metabolism Group, led by Dr Kathleen Gillespie, has been described as an exceptional training environment for postgraduate students.
- NIHR award for Prof Julian Hamilton-Sheild 6 January 2017 Professor Julian Hamilton-Shield has lift off for an i4i NIHR study to undertake a study on "Evaluation and validation of a breath ammonia measurement technology for the improved management of patients with urea cycle defects".